Tetrapharm Bioengineering ApS
CVR 46672909 · Private limited company (ApS) · Active · High risk
Tetrapharm Bioengineering ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 4.5% over the next 12 months, which is 3.2 times the average for Danish companies. CEO: Ulrich Wulff Norden Venge.
Bankruptcy risk for Tetrapharm Bioengineering ApS
3.2 × the average (1.41%) · higher risk than 91% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46672909
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- c/o Tetra Pharm, Ørestads Boulevard 108
2300 København S - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 20k
- Auditor
- MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 18 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ulrich Wulff Norden Venge | Current | |
| CEO | Jesper Breum | ||
| CEO | Martin Stefan Rose | ||
| Board | Claus Berner Nielsen | Current | |
| Board | Jesper Breum | Current | |
| Board | Søren Maarssø | Current | |
| Board | Rolf Sass Sørensen | Current | |
| Owner (100%) | Tetra Pharm Technologies ApS | Current | |
| Auditor | MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Tetra Pharm Technologies ApS | Current |
The CEOs' other companies
Ulrich Wulff Norden Venge – 11 other companies, of which 1 bankrupt
- Deemly ApS Bankrupt 2 Feb 2021
- CCL PeopleCo Côte d Azur ApS Active
- Copenhagen Coffee Lab ApS Active
- Copenhagen Coffee Lab Holding ApS Active
- Klemmen Espressoservice ApS Fusioneret
- Klinikdrift IVS Fusioneret
- Kliniksupport IVS Fusioneret
- SolarImpact A/S Active
- TANDLÆGERNE VENGE ApS Active
- Tetra Pharm Technologies ApS Active
- Tetrapharm Therapeutics ApS Active
Jesper Breum – 5 other companies
- Breum Holding EST. 2016 ApS Active
- CFF Investment EST 2016 ApS Active
- Tetra Pharm Technologies ApS Active
- Tetrapharm Therapeutics ApS Active
- XBR Invest ApS Active
Martin Stefan Rose – 4 other companies
- BrainFrame ApS Active
- Tetra Pharm Technologies ApS Active
- Tetrapharm Therapeutics ApS Active
- XBR Invest ApS Active
Address history (0 moves)
| c/o Tetra Pharm, Ørestads Boulevard 108, 2300 København S |
Other companies at the same address
- Atnahs Pharma Denmark ApS Active
- COMCARE A/S Fusioneret
- Cellnex Denmark ApS Active
- ERICSSON DANMARK A/S Active
- Finest Cask ApS Active
- Intellis A/S Active
- On Tower Denmark ApS Active
- PHILIP MORRIS ApS Active
- PIXLAB A/S Active
- Pharmanovia A/S Active
- Punktum dk A/S Active
- S. LARSEN HOLDING ApS Active
- STANDOUT A/S Active
- Standoutmedia Holding ApS Active
- TENET A/S Active
- Tetra Pharm Technologies ApS Active
- Tetrapharm Therapeutics ApS Active
- iBridge Consulting ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
- Linker Pharmaceuticals ApS København K
Questions and answers about Tetrapharm Bioengineering ApS
Has Tetrapharm Bioengineering ApS gone bankrupt?
No, Tetrapharm Bioengineering ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Tetrapharm Bioengineering ApS?
Our model estimates a bankruptcy risk of 4.5% over the next 12 months (high risk), which is 3.2 times the average for Danish companies.
Who is the CEO of Tetrapharm Bioengineering ApS?
Ulrich Wulff Norden Venge is the CEO of Tetrapharm Bioengineering ApS.
Who is the auditor of Tetrapharm Bioengineering ApS?
Tetrapharm Bioengineering ApS most recently used MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Tetrapharm Bioengineering ApS founded?
Tetrapharm Bioengineering ApS was founded on 31 July 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.